{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:48:39Z","timestamp":1786736919906,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijd.ijd_37_19","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T02:52:20Z","timestamp":1586832740000},"page":"193","source":"Crossref","is-referenced-by-count":16,"title":["Nail changes induced by chemotherapeutic agents"],"prefix":"10.4103","volume":"65","author":[{"given":"Aradhana","family":"Sood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neerja","family":"Saraswat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhramesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-5154.282451-1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.det.2007.08.003","article-title":"Malignancy and cancer treatment-related hair and nail changes","author":"Hinds","year":"2008","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/0019-5154.282451-2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00002018-199921030-00004","article-title":"Drug-induced nail disorders","author":"Piraccini","year":"1999","journal-title":"Drug Safety"},{"key":"key-10.4103\/0019-5154.282451-3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.det.2006.03.004","article-title":"Drug induced nail diseases","author":"Piraccini","year":"2006","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/0019-5154.282451-4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.det.2007.01.006","article-title":"Drug reactions affecting the nail unit: Diagnosis and management","author":"Piraccini","year":"2007","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/0019-5154.282451-5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00128071-200304010-00004","article-title":"Drug-induced nail abnormalities","author":"Piraccini","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"key-10.4103\/0019-5154.282451-6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1468-3083.2004.00775.x","article-title":"Drugs and nails","author":"Uyttendaele","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0019-5154.282451-7","first-page":"434","article-title":"Dermatological adverse reactions to cancer chemotherapy","author":"Pavey","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0019-5154.282451-8","first-page":"334","article-title":"Nail changes secondary to hematologic conditions","author":"Vassallo","year":"2001","journal-title":"Haematologica"},{"key":"key-10.4103\/0019-5154.282451-9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0190-9622(99)70488-3","article-title":"Mucocutaneous reactions to chemotherapy","author":"Susser","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.282451-10","first-page":"548","article-title":"Cyclophosphamide and pigmentation","author":"Harrison","year":"1972","journal-title":"Br Med J"},{"key":"key-10.4103\/0019-5154.282451-11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0140-6736(75)90916-2","article-title":"Cyclophosphamide-induced nail pigmentation","author":"Shah","year":"1975","journal-title":"Lancet"},{"key":"key-10.4103\/0019-5154.282451-12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2133.1978.tb03587.x","article-title":"Cyclophosphamide induced nail pigmentation","author":"Shah","year":"1978","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.282451-13","first-page":"35","article-title":"Cyclophosphamide nail pigmentation","author":"Adam","year":"1981","journal-title":"Sing Med J"},{"key":"key-10.4103\/0019-5154.282451-14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2141.2002.03449.x","article-title":"Cyclophosphamide-induced nail pigmentation","author":"Srikanth","year":"2002","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0019-5154.282451-15","first-page":"14","article-title":"Peculiar pattern of nail pigmentation following cyclophosphamide therapy","author":"Dave","year":"2003","journal-title":"Dermatol Online J"},{"key":"key-10.4103\/0019-5154.282451-16","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0140-6736(75)92341-7","article-title":"Adriamycin and longitudinal pigmented banding of fingernails","author":"Priestman","year":"1975","journal-title":"Lancet"},{"key":"key-10.4103\/0019-5154.282451-17","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/archderm.1990.01670330124031","article-title":"Onycholysis in doxorubicin-treated patients","author":"Curran","year":"1990","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0019-5154.282451-18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/0378-6323.19727","article-title":"Imatinib-induced nail hyperpigmentation in chronic myeloid leukemia","author":"Prabhash","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/0019-5154.282451-19","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/archderm.1997.03890470146034","article-title":"Docetaxel chemotherapy induces transverse superficial loss of the nail plate","author":"Llombart-Cussac","year":"1997","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0019-5154.282451-20","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1046\/j.1365-2133.2003.05272.x","article-title":"Exudative hyponychial dermatitis associated with capecitabine and docetaxel combination chemotherapy for metastatic breast carcinoma: Report of three cases","author":"Chen","year":"2003","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.282451-21","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1200\/JCO.1995.13.12.2886","article-title":"Phase II trial of docetaxel: A new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer","author":"Valero","year":"1995","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0019-5154.282451-22","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/archderm.134.9.1167","article-title":"Nail bed dyschromia secondary to docetaxel therapy","author":"Jacob","year":"1998","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0019-5154.282451-23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2133.2002.46824.x","article-title":"Nail changes due to docetaxel","author":"Pavithran","year":"2002","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0019-5154.282451-24","first-page":"15","article-title":"Nail toxicity related to taxanes","author":"Mourad","year":"2003","journal-title":"Dermatol Online J"},{"key":"key-10.4103\/0019-5154.282451-25","first-page":"865","article-title":"Chemotherapy induced transverse leukonychia (Mees' lines)","author":"Parakh","year":"2007","journal-title":"Indian Pediatr"},{"key":"key-10.4103\/0019-5154.282451-26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1100\/tsw.2011.27","article-title":"Mees' lines","author":"Mirfazaelian","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"key-10.4103\/0019-5154.282451-27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.7241\/ourd.20133.95","article-title":"Mees' lines following chemotherapy","author":"Kumar","year":"2013","journal-title":"Our Dermatol Online"},{"key":"key-10.4103\/0019-5154.282451-28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1525-1470.1997.tb00222.x","article-title":"Transverse leukonychia (Mees' lines) due to aunorubidn chemotherapy","author":"Shelley","year":"1997","journal-title":"Pediatr Dermatol"},{"key":"key-10.4103\/0019-5154.282451-29","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMicm1801702","article-title":"Nail changes during chemotherpy","author":"Alzahrani","year":"2018","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0019-5154.282451-30","first-page":"10","article-title":"Distinct patterns of chromonychia, Beau's lines, and melanoderma seen with vincristine, adriamycin, dexamethasone therapy for multiple myeloma","author":"Dasanu","year":"2006","journal-title":"Dermatol Online J"},{"key":"key-10.4103\/0019-5154.282451-31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000206708","article-title":"Cancer chemotherapy and nail loss (Onychomadesis)\/Meningeal relapse in acute promyelocytic leukaemia","author":"Kochupillai","year":"1983","journal-title":"Acta Haematol"},{"key":"key-10.4103\/0019-5154.282451-32","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2367::AID-CNCR22>3.0.CO;2-#","article-title":"Onycholysis as a complication of systemic chemotherapy: Report of five cases associated with prolonged weekly paclitaxel therapy and review of the literature","author":"Hussain","year":"2000","journal-title":"Cancer"},{"key":"key-10.4103\/0019-5154.282451-33","first-page":"234","article-title":"Onycholysis with the appearance of a \u201csunset\u201d secondary to capecitabine","author":"Maino","year":"2003","journal-title":"Cutis"},{"key":"key-10.4103\/0019-5154.282451-34","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1067\/mjd.2002.124621","article-title":"Paronychia induced by cetuximab, an antiepidermal growth factor receptor antibody","author":"Boucher","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0019-5154.282451-35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1346-8138.2003.tb00387.x","article-title":"Paronychia induced by gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor","author":"Nakano","year":"2003","journal-title":"J Dermatol"},{"key":"key-10.4103\/0019-5154.282451-36","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJMicm040187","article-title":"Images in clinical medicine.Beau's lines","author":"Mortimer","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0019-5154.282451-37","first-page":"55","article-title":"Exudative onycholysis and acute bacterial paronychia related to BIBF-1120 and paclitaxel: Response to topical therapy","author":"Freites-Mart\u00ednez","year":"2014","journal-title":"Invest Clin"},{"key":"key-10.4103\/0019-5154.282451-38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1468-3083.2006.01887.x","article-title":"Nail changes associated with chemotherapy in children","author":"Chen","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0019-5154.282451-39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/annonc\/mdg050","article-title":"Taxane-induced nail changes: Incidence, clinical presentation and outcome","author":"Minisini","year":"2003","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0019-5154.282451-40","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00520-007-0232-0","article-title":"Nail changes due to docetaxel\u2014a neglected side effect and nuisance for the patient","author":"Winther","year":"2007","journal-title":"Support Care Cancer"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:47:50Z","timestamp":1786733270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.IJD_37_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"alternative-id":["282451"],"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_37_19","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}